HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G hemostasis range of instruments. The new Yumizen GDDi 2 (D-Dimer) reagent kit is now available for HORIBA Medical’s ...

HORIBA UK Ltd, Medical announces that it has launched its new look blood cell morphology focused newsletter which draws on and shares HORIBA Medical’s hematology expertise with a broad audience. The ...

HORIBA Medical announces that it will be showcasing the very latest additions to its Yumizen G range of hemostasis analyzers and reagents at ISTH 2022 Congress - the premier event in the field of ...

HORIBA, a global leader in spectroscopy with over 200 years’ experience, joins the lifETIME Centre for Doctoral Training in engineered tissues for discovery, industry & medicine NORTHAMPTON, UK (6 ...

HORIBA Medical has launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved. Following the success of HORIBA Medical’s previous HELO, this new generation ...

Horiba has joined a consortium aimed at accelerating the development of process analytical technologies for cell and gene therapy manufacturing Horiba, a manufacturer of measurement and analytical ...

Northampton, UK – 9 th October 2020 – HORIBA UK Ltd, Medical has recently received recognition for a new partnership with Britannia Pharmaceuticals and Northumberland Tyne & Wear Mental Health Trust ...

HORIBA, one of the global leaders in a wide range of medical diagnostic equipment, and SigTuple, a medtech company that develops AI-powered digital microscopy solutions, announced today a partnership ...

HORIBA India, a group company of HORIBA, Ltd., a Kyoto based Japanese leader in analytical equipment and measurement solutions for the three megatrend fields of energy & environment, bio & healthcare, ...